HR-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer (Companion Faculty Lecture)
Research To Practice | Oncology Videos · Dr. Neil Love
October 25, 202422m 53s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring a slide presentation and related discussion from Dr Erika Hamilton, including the following topics:
- Targeted therapies for ER-positive breast cancer (0:00)
- Clinical data with oral selective estrogen receptor degraders (2:13)
- Biological rationale for and mechanism of action of proteolysis-targeting chimeras (PROTACs) (7:07)
- Emerging data with PROTACs for ER-positive advanced breast cancer (9:17)
- Future directions with PROTACs for breast cancer (19:21)